STOCK TITAN
  1. Home
  2. Sec-filings
  3. STOK
  4. [EFFECT] Stoke Therapeutics, Inc. SEC Filing

[EFFECT] Stoke Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2025 4:00 P.M.
Form: S-3
CIK: 0001623526
Company Name: Stoke Therapeutics, Inc.
File Number: 333-288583

Source: View Original Filing on SEC EDGAR

Stock STOK logo
Stoke Therapeutics

NASDAQ:STOK

STOK Rankings

#2619 Ranked by Market Cap
N/A Ranked by Dividends

STOK Latest News

Aug 28, 2025
Stoke Therapeutics to Present at Upcoming Investor Conferences in September 2025
Aug 18, 2025
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Aug 12, 2025
Stoke Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates
Aug 7, 2025
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Second Quarter 2025 Business and Financial Updates
Aug 6, 2025
Stoke Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference

STOK Latest SEC Filings

Aug 29, 2025
[144] Stoke Therapeutics, Inc. SEC Filing
Aug 29, 2025
[144] Stoke Therapeutics, Inc. SEC Filing
Aug 26, 2025
[SCHEDULE 13D/A] Stoke Therapeutics, Inc. SEC Filing
Aug 20, 2025
[Form 4] Stoke Therapeutics, Inc. Insider Trading Activity
Aug 20, 2025
[Form 4] Stoke Therapeutics, Inc. Insider Trading Activity

STOK Stock Data

1.06B
52.26M
4.58%
120.01%
20.94%
Biotechnology
Pharmaceutical Preparations
Link
United States
BEDFORD